Does TRAMETINIB DIMETHYL SULFOXIDE Cause Second primary malignancy? 77 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 77 reports of Second primary malignancy have been filed in association with TRAMETINIB DIMETHYL SULFOXIDE (Mekinist). This represents 0.5% of all adverse event reports for TRAMETINIB DIMETHYL SULFOXIDE.
77
Reports of Second primary malignancy with TRAMETINIB DIMETHYL SULFOXIDE
0.5%
of all TRAMETINIB DIMETHYL SULFOXIDE reports
22
Deaths
20
Hospitalizations
How Dangerous Is Second primary malignancy From TRAMETINIB DIMETHYL SULFOXIDE?
Of the 77 reports, 22 (28.6%) resulted in death, 20 (26.0%) required hospitalization, and 2 (2.6%) were considered life-threatening.
Is Second primary malignancy Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TRAMETINIB DIMETHYL SULFOXIDE. However, 77 reports have been filed with the FAERS database.
What Other Side Effects Does TRAMETINIB DIMETHYL SULFOXIDE Cause?
Death (2,998)
Pyrexia (2,660)
Rash (1,271)
Fatigue (1,143)
Malignant neoplasm progression (1,114)
Nausea (1,085)
Chills (965)
Diarrhoea (867)
Vomiting (720)
Product use in unapproved indication (687)
What Other Drugs Cause Second primary malignancy?
CYCLOPHOSPHAMIDE (1,247)
DOXORUBICIN (1,151)
VINCRISTINE (908)
IMATINIB (763)
PALBOCICLIB (658)
RITUXIMAB (646)
RUXOLITINIB (611)
ETOPOSIDE (573)
PREDNISONE (517)
OCTREOTIDE (496)
Which TRAMETINIB DIMETHYL SULFOXIDE Alternatives Have Lower Second primary malignancy Risk?
TRAMETINIB DIMETHYL SULFOXIDE vs TRANDOLAPRIL
TRAMETINIB DIMETHYL SULFOXIDE vs TRANDOLAPRIL\VERAPAMIL
TRAMETINIB DIMETHYL SULFOXIDE vs TRANEXAMIC ACID
TRAMETINIB DIMETHYL SULFOXIDE vs TRANYLCYPROMINE
TRAMETINIB DIMETHYL SULFOXIDE vs TRASTUZUMAB